First Time Loading...
P

PKU HealthCare Corp Ltd
SZSE:000788

Watchlist Manager
PKU HealthCare Corp Ltd
SZSE:000788
Watchlist
Price: 6.43 CNY 7.17% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one PKU HealthCare Corp Ltd stock under the Base Case scenario is 6.5 CNY. Compared to the current market price of 6.43 CNY, PKU HealthCare Corp Ltd is Undervalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6.5 CNY
Undervaluation 1%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
76
vs Industry
60
Median 3Y
1.9
Median 5Y
1.8
Industry
2.5
More Details
68
P/E
P/E
Price to Earnings
68
vs History
92
vs Industry
6
Median 3Y
79
Median 5Y
82.9
Industry
23.4
More Details
17.9
P/OCF
P/OCF
Price to OCF
17.9
vs History
50
vs Industry
26
Median 3Y
19.1
Median 5Y
17
Industry
17.4
More Details
110.9
P/FCFE
P/FCFE
Price to FCFE
110.9
vs History
30
vs Industry
6
Median 3Y
90.3
Median 5Y
29.4
Industry
23.6
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
92
vs Industry
33
Median 3Y
3
Median 5Y
3.1
Industry
2.1
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
66
vs Industry
59
Median 3Y
1.9
Median 5Y
1.8
Industry
2.6
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
36
vs Industry
43
Median 3Y
5.3
Median 5Y
4.5
Industry
5.2
More Details
45.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
45.9
vs History
80
vs Industry
7
Median 3Y
47.3
Median 5Y
47.3
Industry
13.7
More Details
45.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.9
vs History
80
vs Industry
10
Median 3Y
47.3
Median 5Y
47.3
Industry
17.2
More Details
18.1
EV/OCF
EV/OCF
Enterprise Value to OCF
18.1
vs History
49
vs Industry
27
Median 3Y
19.3
Median 5Y
16.6
Industry
16.2
More Details
24.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.2
vs History
44
vs Industry
19
Median 3Y
25.8
Median 5Y
19.8
Industry
17.8
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
92
vs Industry
38
Median 3Y
2.4
Median 5Y
2.6
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
PKU HealthCare Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
PKU HealthCare Corp Ltd
SZSE:000788
3.8B CNY 1.8 68 45.9 45.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
739.2B USD 20.6 120.4 59 67.1
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 16.2 44.3 33 36.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
357.9B USD 4.2 9.3 11.5 15
US
Merck & Co Inc
NYSE:MRK
330.2B USD 5.4 143.2 35.7 58.2
UK
AstraZeneca PLC
LSE:AZN
190.5B GBP 5 37.6 174.5 278.4
CH
Roche Holding AG
SIX:ROG
176.6B CHF 3 15.4 8.7 10.4
CH
Novartis AG
SIX:NOVN
177.4B CHF 3.3 11.1 8.5 12.4
US
Pfizer Inc
NYSE:PFE
156.8B USD 2.8 -507.4 12.6 20.1
P/E Multiple
Earnings Growth
CN
P
PKU HealthCare Corp Ltd
SZSE:000788
Average P/E: 56.2
68
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
120.4
346%
DK
Novo Nordisk A/S
CSE:NOVO B
44.3
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.3
-20%
US
Merck & Co Inc
NYSE:MRK
143.2
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.6
168%
CH
Roche Holding AG
SIX:ROG
15.4
26%
CH
Novartis AG
SIX:NOVN
11.1
15%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -507.4
680%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.